LENZ logo

LENZ Therapeutics (LENZ)

Profile

Full Name

LENZ Therapeutics, Inc.

Ticker Symbol

LENZ

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 22, 2024

Indexes

Not included

Website

http://www.lenz-tx.com

Employees

6

Key Details

Price

$25.62

Market Cap

$705.65M(Small cap)

Last Dividend

$1.03

TTM Dividend Yield

4.02%

Annual Revenue

-

Annual EPS

-$2.34(+14.60% YoY)

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$25.62
LENZ price is $25.62

Price All-time High

$37.37
LENZ price is currently -31.44% below its historical high of $37.37

Price Today Change

-0.08%
LENZ price is down -0.08% today

Price YTD Change

-11.26%
LENZ price is down -11.26% since January 1st

Price 1-year Change

+14.73%
LENZ price is up +14.73% year-on-year

Price 3-year Change

-
LENZ price 3-year change is unknown

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$705.65M
LENZ market capitalization is $705.65 million

Market Cap 3-year Change

-
LENZ market capitalization 3-year change is unknown

Market Cap All-time High

$1.03B
LENZ market capitalization is currently -31.34% below its historical high of $1.03 billion

Market Cap Sector Rank

72.48%
LENZ market capitalization is higher than 72.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.87%
LENZ shares outstanding is up +7.87% year-on-year

Shares Outstanding 3-Year Change

-
LENZ shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.72
LENZ beta is 1.72

200-day SMA

$25.30
LENZ price is currently +1.28% above its 200-day simple moving average

50-day SMA

$24.45
LENZ price is currently +4.76% above its 50-day simple moving average

RSI

54.15
LENZ 14-day relative strength index is 54.15

Volume

1.18
LENZ 30-day relative volume is 1.18

ATR

$1.85
LENZ average true range is $1.85

10-day Historical Volatility

56.22%
LENZ 10-day historical volatility is 56.22%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.03
LENZ last dividend was $1.03 per share, with an ex-dividend date of March 22, 2024

Next Dividend

-
LENZ next dividend has not yet been announced

Dividend per share

Dividend Per Share

$1.03
LENZ annual dividend per share is $1.03

Dividend per share Sector Rank

41.18%
LENZ annual dividend per share is higher than 41.18% of companies in Healthcare sector

Dividend per share 1-Year Change

-
LENZ annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
LENZ annual dividend per share 3-year change is unknown

Dividend yield

Dividend Yield

4.02%
LENZ annual dividend yield is 4.02%

Dividend yield Sector Rank

82.14%
LENZ annual dividend yield is higher than 82.14% of companies in Healthcare sector

Other

Payout Ratio

-
LENZ annual payout ratio value is unknown

Dividends Paid

-
LENZ annual dividends paid value is unknown

Free Cash Flow

-$59.86M
LENZ annual free cash flow is -$59.86 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
LENZ annual revenue value is unknown

Revenue Analysts Estimate

$7.63M
LENZ annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year Change

-
LENZ annual revenue 1-year change is unknown

Revenue Sector Rank

-
LENZ annual revenue is unknown

EPS

EPS

-$2.34
LENZ annual earnings per share is -$2.34

EPS Analysts Estimate

-$3.32
LENZ annual earnings per share is currently -29.53% lower than the consensus analysts' forecast

EPS 1-year Change

+14.6%
LENZ annual earnings per share is up +14.6% year-on-year

EPS Sector Rank

35.93%
LENZ annual earnings per share is higher than 35.93% of companies in Healthcare sector

Profit

Gross Profit

-
LENZ annual gross profit value is unknown

Gross Margin

-
LENZ annual gross profit margin value is unknown

Operating Profit

-$58.61M
LENZ annual operating income is -$58.61 million

Operating Margin

-
LENZ annual operating profit margin value is unknown

Net Income

-$49.77M
LENZ annual net profit is -$49.77 million

Net Margin

-
LENZ annual net profit margin value is unknown

Expenses

Total Expenses

$58.61M
LENZ annual total expenses is $58.61 million

Operating Expenses

$58.61M
LENZ annual total operating expenses is $58.61 million

Cost Of Goods Sold

-
LENZ annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$28.81M
LENZ annual SGA is $28.81 million

Depreciation And Amortization

$58.00K
LENZ annual depreciation & amortization is $58.00 thousand

Interest Expense

-
LENZ annual interest expense value is unknown

Income Tax

$1000.00
LENZ annual income tax is $1000.00

EBIT & EBITDA

EBIT

-$58.61M
LENZ annual earnings before interest & taxes is -$58.61 million

EBITDA

-$58.55M
LENZ annual EBITDA is -$58.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$215.30M
LENZ annual total assets is $215.30 million

Non Current Assets

$3.39M
LENZ annual long term assets is $3.39 million

Current Assets

$211.92M
LENZ annual total current assets is $211.92 million

Cash And Cash Equivalents

$20.16M
LENZ annual cash & cash equivalents is $20.16 million

Accounts Receivable

-
LENZ annual accounts receivable value is unknown

Inventory

-
LENZ annual inventory value is unknown

Liabilities

Total Liabilities

$11.22M
LENZ annual total liabilities is $11.22 million

Long Term Liabilities

$814.00K
LENZ annual total long term liabilities is $814.00 thousand

Current Liabilities

$10.41M
LENZ annual total current liabilities is $10.41 million

Accounts Payable

$4.26M
LENZ annual accounts payable is $4.26 million

Debt

Total Debt

$1.38M
LENZ annual total debt is $1.38 million

Total Debt 1-year Change

+319.76%
LENZ annual total debt is up +319.76% year-on-year

Long Term Debt

$814.00K
LENZ annual long term debt is $814.00 thousand

Short Term Debt

$567.00K
LENZ annual short term debt is $567.00 thousand

Equity & Capital

Shareholders Equity

$204.08M
LENZ annual stockholders equity is $204.08 million

Book Value

$204.08M
LENZ annual book value is $204.08 million

Retained Earnings

-$145.01M
LENZ annual retained earnings is -$145.01 million

Working Capital

$201.51M
LENZ annual working capital is $201.51 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$59.39M
LENZ annual cash flow from operations is -$59.39 million

Cash From Operations 1-year Change

+1.64%
LENZ annual cash flow from operations is up +1.64% year-on-year

Cash From Investing

-$154.48M
LENZ annual cash flow from investing activities is -$154.48 million

Cash From Investing 1-year Change

-421.52%
LENZ annual cash flow from investing activities is down -421.52% year-on-year

Cash From Financing

$199.00M
LENZ annual cash flow from financing activities is $199.00 million

Cash From Financing 1-year Change

+146.59%
LENZ annual cash flow from financing activities is up +146.59% year-on-year

CAPEX

CAPEX

-
LENZ annual capital expenditures value is unknown

CAPEX 1-year Change

-
LENZ annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

-$59.86M
LENZ annual free cash flow is -$59.86 million

Free Cash Flow 1-year Change

+0.91%
LENZ annual free cash flow is up +0.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
LENZ annual gross profit margin value is unknown

Operating Margin

-
LENZ annual operating profit margin value is unknown

Net Margin

-
LENZ annual net profit margin value is unknown

ROA & ROE

ROA

-23.12%
LENZ annual return on assets is -23.12%

ROE

-24.39%
LENZ annual return on equity is -24.39%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
LENZ price to earnings ratio value is unknown

PE Ratio Sector Rank

-
LENZ price to earnings ratio is unknown

PB Ratio

PB Ratio

3.46
LENZ price to book ratio is 3.46

PB Ratio Sector Rank

74.86%
LENZ price to book ratio is higher than 74.86% of companies in Healthcare sector

PS Ratio

PS Ratio

-
LENZ price to sales ratio value is unknown

PS Ratio Sector Rank

-
LENZ price to sales ratio is unknown

Enterprise value

Enterprise Value

$686.87M
LENZ enterprise value is $686.87 million

Enterprise Value Sector Rank

71.31%
LENZ enterprise value is higher than 71.31% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.73
LENZ EV/EBITDA is -11.73

EV/EBITDA Sector Rank

10.31%
LENZ EV/EBITDA is higher than 10.31% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

20.36
LENZ annual current ratio is 20.36

Quick Ratio

-
LENZ annual quick ratio value is unknown

Leverage

Debt To Equity

0.01
LENZ annual debt to equity ratio is 0.01

Interest Coverage Ratio

-
LENZ annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
LENZ piotroski f-score value is unknown

Altman Z-Score

-
LENZ altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 20, 25 Citigroup
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Sep 27, 24 Raymond James
Outperform
Aug 15, 24 Piper Sandler
Overweight
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Apr 15, 24 William Blair
Outperform
Apr 15, 24 Leerink Partners
Outperform
Apr 10, 24 Citigroup
Buy
Mar 27, 24 Piper Sandler
Overweight

Institutional Ownership

Similar stocks

CMRX logo
Chimerix (CMRX)
REPL logo
Replimune (REPL)
AVDL logo
Avadel Pharmaceuticals (AVDL)
RCUS logo
Arcus Biosciences (RCUS)
MYGN logo
Myriad Genetics (MYGN)
EOLS logo
Evolus (EOLS)
WEAV logo
Weave Communications (WEAV)
AXGN logo
AxoGen (AXGN)
Fortrea Holdings (FTRE)
  • What is the ticker symbol for LENZ Therapeutics?
  • Does LENZ Therapeutics pay dividends?
  • What sector is LENZ Therapeutics in?
  • What industry is LENZ Therapeutics in?
  • What country is LENZ Therapeutics based in?
  • When did LENZ Therapeutics go public?
  • Is LENZ Therapeutics in the S&P 500?
  • Is LENZ Therapeutics in the NASDAQ 100?
  • Is LENZ Therapeutics in the Dow Jones?
  • When was LENZ Therapeutics's last earnings report?
  • When does LENZ Therapeutics report earnings?
  • Should I buy LENZ Therapeutics stock now?

What is the ticker symbol for LENZ Therapeutics?

The ticker symbol for LENZ Therapeutics is NASDAQ:LENZ

Does LENZ Therapeutics pay dividends?

Yes, LENZ Therapeutics pays dividends. The last payment was $1.03, with an ex-dividend date on March 22, 2024

What sector is LENZ Therapeutics in?

LENZ Therapeutics is in the Healthcare sector

What industry is LENZ Therapeutics in?

LENZ Therapeutics is in the Biotechnology industry

What country is LENZ Therapeutics based in?

LENZ Therapeutics is headquartered in United States

When did LENZ Therapeutics go public?

LENZ Therapeutics's initial public offering (IPO) was on March 22, 2024

Is LENZ Therapeutics in the S&P 500?

No, LENZ Therapeutics is not included in the S&P 500 index

Is LENZ Therapeutics in the NASDAQ 100?

No, LENZ Therapeutics is not included in the NASDAQ 100 index

Is LENZ Therapeutics in the Dow Jones?

No, LENZ Therapeutics is not included in the Dow Jones index

When was LENZ Therapeutics's last earnings report?

LENZ Therapeutics's most recent earnings report was on Mar 19, 2025

When does LENZ Therapeutics report earnings?

The next expected earnings date for LENZ Therapeutics is May 30, 2025

Should I buy LENZ Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page